CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


Aratana Therapeutics, Inc.  (PETX)
Other Ticker:  
 
    Sector  Healthcare    Industry Major Pharmaceutical Preparations
 
 

PETX's Revenue Year on Year Growth by Quarter and Year

Aratana Therapeutics,'s Revenue results by quarter and year



Select the Comparisons : Select the Ratio:                        
PETX Revenue (in millions $) FY 2017 FY 2016 FY 2015 FY 2014
IV Quarter December - 0.04 0.23 0.04
III Quarter September - 38.05 0.23 0.30
II Quarter June 5.16 0.17 0.16 0.18
I Quarter March 3.80 0.06 0.25 -0.56
FY   8.96 38.32 0.87 -0.04

Financial Statements
Aratana Therapeutics,'s second quarter 2017 Revenue $ 5.16 millions PETX's Income Statement
Aratana Therapeutics,'s second quarter 2016 Revenue $ 0.17 millions Quarterly PETX's Income Statement
PETX's Growth by Division See PETX's Growth by Segment

PETX Revenue ( Y/Y Growth %) 2017
2016 2015 2014
IV Quarter December - -82.61 % 475 % -
III Quarter September - 16443.48 % -23.33 % -
II Quarter June 2934.12 % 6.25 % -11.11 % -
I Quarter March 6233.33 % -76 % - -
FY   - 4304.6 % - -



PETX Revenue Growth Comment
Aratana Therapeutics, Inc. achieved in the second quarter, above Company average Revenue surge of 2934.12% year on year, to $ 5.16 millions.

Looking into second quarter results within Major Pharmaceutical Preparations industry 121 other companies have achieved higher Revenue growth. While Aratana Therapeutics, Inc.' s Revenue doubling of 2934.12% ranks overall at the positon no. 3374 in the second quarter.



Revenue Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #122
Healthcare Sector #428
Overall #3374
Revenue Y/Y Growth Statistics
High Average Low
16442.17 % 2079.23 % -86.44 %
(Jun 30 2016)   (Jun 30 2017)

You need to upgrade your Flash Player

Other Revenue Growth
Major Pharmaceutical Preparations Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
PETX's Revenue Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for PETX's Competitors
Revenue Growth for Aratana Therapeutics,'s Suppliers
Revenue Growth for PETX's Customers

You may also want to know
PETX's Annual Growth Rates PETX's Profitability Ratios PETX's Asset Turnover Ratio PETX's Dividend Growth
PETX's Roe PETX's Valuation Ratios PETX's Financial Strength Ratios PETX's Dividend Payout Ratio
PETX's Roa PETX's Inventory Turnover Ratio PETX's Growth Rates PETX's Dividend Comparisons



Companies with similar Revenue doubling for the quarter ending Jun 30 2017 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jun 30 2017
Manhattan Scientifics Inc  4,000.00 %$ 4,000.000 millions
Jaguar Health, Inc.  3,613.38 %$ 3,613.379 millions
Clearside Biomedical, Inc.  2,500.00 %$ 2,500.000 millions
Xoma Corp  2,358.24 %$ 2,358.239 millions
Epizyme, Inc.  2,014.16 %$ 2,014.165 millions
Sophiris Bio Inc.  1,666.67 %$ 1,666.667 millions